Trial Profile
The Effect of Androgen Deprivation Therapy on Regulation of Muscle Protein Metabolism and Blood Glucose
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 29 Mar 2023
Price :
$35
*
At a glance
- Drugs Goserelin (Primary)
- Indications Prostate cancer
- Focus Pharmacodynamics
- 23 Mar 2023 Status changed from recruiting to discontinued.
- 28 Sep 2022 Planned End Date changed from 1 Aug 2022 to 1 Jun 2023.
- 28 Sep 2022 Planned primary completion date changed from 4 Apr 2022 to 26 Dec 2022.